Free tool
Heavily traded stocks
We cover 15 companies whose typical session turns over more than $10.00M. The median market value in the group is $258.56B. Across the group, the median move over the past trading day is −1.09%. Price change over the past year runs from −39.8% to +60.2% across the middle 80 percent of the group, with a median of +15.2%.
Other lists in this group
Table
15 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% | Nov 4, 2026 |
| 4563.T | AnGes, Inc. | $97.61M | Micro cap | −60.42% | Nov 6, 2026 |
| 4582.T | SymBio Pharmaceuticals Limited | $31.19M | Micro cap | −57.43% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.